Integra LifeSciences to Sell Extremity Orthopedics Business to Smith+Nephew
Integra Lifesciences announced a definitive agreement to divest its Extremity Orthopedics business to Smith+Nephew for $240 million. Sep 29, 2020
We've found 286 results
Spinal Elements Files for $100 Million IPO
The company posted 2018 and 2019 revenue of $90.8 million and $95.9 million, respectively, growing +5.6% year over year. Sep 28, 2020
28 Funding Announcements in 2020
The number of funding disclosures in 2020 demonstrates investment interest in orthopedics’ smaller companies and novel technologies even amongst COVID-19s hit on the industry. Sep 24, 2020
WishBone on a Mission to Bridge the Gap in Pediatric Orthopedics
CEO Nick Deeter says that 95% of children continue to receive adult orthopedic products that were never intended for them nor cleared by FDA for use in children. WishBone seeks to change the paradigm of pediatric orthopedics with its child-focused implants and sterile packaged disposable kits. Sep 23, 2020
Spine Surgeon Reflects on Riding the Elective Surgery Rollercoaster
Eeric Truumees, M.D., First Vice President of NASS’ Board of Directors, is optimistic that the online virtual annual meeting event in October will allow attendees to benefit from broader input in smaller doses. Sep 23, 2020
MicroPort Orthopedics Focuses on Portfolio Expansion During COVID Slowdown
The company's exposure in global markets caused revenue declines of -24% in 1H20, but MicroPort launched several new products to spur future growth Sep 02, 2020
Episurf Medical Reached Milestone 800th Implant of Episealer
The Sweden-based company reached another milestone for the Episealer knee implant, as it plans the 800th surgery for the product. Aug 24, 2020
Garwood Medical Devices Announces Series C Funding
The $4 million round will support additional preclinical testing for the BioPrax device to eliminate biofilm infections on prosthetic joints. Aug 21, 2020
COVID-19 Disruption Accelerates Orthopedic Opportunities in Ambulatory Surgery
The impact of COVID-19 is vacillating between acute and chronic. There is both need and opportunity for a dedicated ambulatory strategy for OEMs. Aug 20, 2020
Medartis Keeps Pace with Priorities Amid COVID
Despite the impact of COVID, the company forged ahead with its priorities, including expanding its U.S. business and accelerating its innovation pipeline. Aug 19, 2020
